OCULAR IMMUNOLOGY AND INFLAMMATION

Scope & Guideline

Illuminating the path to understanding ocular inflammation.

Introduction

Welcome to your portal for understanding OCULAR IMMUNOLOGY AND INFLAMMATION, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN0927-3948
PublisherTAYLOR & FRANCIS INC
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1993 to 2024
AbbreviationOCUL IMMUNOL INFLAMM / Ocul. Immunol. Inflamm.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106

Aims and Scopes

The journal "Ocular Immunology and Inflammation" is dedicated to advancing the understanding of ocular inflammatory diseases and their immune responses. It encompasses a wide range of topics, including clinical management, pathophysiology, and innovative treatment approaches.
  1. Ocular Inflammatory Diseases:
    The journal focuses on various ocular inflammatory diseases, particularly uveitis, scleritis, and related conditions, examining their etiology, clinical features, and management strategies.
  2. Immune Response Mechanisms:
    Research articles explore the immunological mechanisms underlying ocular inflammation, including the roles of cytokines, autoantibodies, and genetic predispositions.
  3. Innovative Therapeutics:
    The journal promotes research on new therapeutic approaches, including biologics and immunomodulatory therapies, aimed at improving patient outcomes in ocular inflammatory diseases.
  4. Diagnostic Advances:
    A significant emphasis is placed on advancements in diagnostic techniques, such as optical coherence tomography (OCT) and angiography, to enhance the detection and monitoring of ocular inflammation.
  5. Epidemiological Studies:
    The journal includes studies investigating the epidemiology and demographic trends associated with ocular inflammatory conditions, providing insights into prevalence and risk factors.
Recent publications in "Ocular Immunology and Inflammation" reflect emerging trends and themes that are gaining traction among researchers. These areas highlight the evolving landscape of ocular inflammatory disease research.
  1. Impact of COVID-19 on Ocular Health:
    The COVID-19 pandemic has spurred a significant increase in studies examining its effects on ocular health, including post-vaccination inflammatory responses and ocular manifestations of the virus.
  2. Role of Artificial Intelligence in Diagnosis:
    There is a rising interest in the application of artificial intelligence and machine learning for diagnosing and managing ocular inflammatory diseases, indicating a shift towards technology-driven approaches.
  3. Microbiome and Ocular Inflammation:
    Research exploring the relationship between the ocular microbiome and inflammatory diseases is gaining momentum, with studies investigating how microbial profiles influence disease onset and progression.
  4. Personalized Medicine Approaches:
    There is an increasing focus on personalized medicine in treating ocular inflammatory conditions, with research aimed at tailoring therapies based on individual patient profiles and responses.
  5. Long-term Outcomes and Quality of Life:
    Emerging research is placing greater emphasis on long-term outcomes and quality of life assessments in patients with ocular inflammatory diseases, highlighting the importance of holistic care.

Declining or Waning

As the field evolves, certain research areas may see a decline in focus or publication frequency. The following themes appear to be waning in prominence in recent publications.
  1. Traditional Pharmacotherapy:
    There is a noticeable decrease in studies focusing solely on traditional pharmacotherapy for ocular inflammation, as newer biologic therapies gain prominence.
  2. Invasive Diagnostic Procedures:
    Research focusing on invasive diagnostic techniques, such as anterior chamber paracentesis or vitrectomy solely for diagnostic purposes, is becoming less common as non-invasive imaging modalities advance.
  3. Single-Cause Inflammatory Theories:
    The trend towards attributing ocular inflammation to single pathogens or causes is declining, with a growing recognition of multifactorial and autoimmune contributions.

Similar Journals

EUROPEAN JOURNAL OF OPHTHALMOLOGY

Advancing Eye Health Through Innovative Research
Publisher: SAGE PUBLICATIONS LTDISSN: 1120-6721Frequency: 6 issues/year

The EUROPEAN JOURNAL OF OPHTHALMOLOGY, published by SAGE PUBLICATIONS LTD, is a leading international journal in the field of ophthalmology, dedicated to advancing the understanding and treatment of ocular diseases and disorders. With an ISSN of 1120-6721 and an E-ISSN of 1724-6016, the journal aims to provide a platform for innovative research, critical reviews, and comprehensive studies that span the diverse aspects of the discipline. As part of its commitment to disseminating high-quality research, the journal is indexed in Scopus, achieving an impressive rank of #47 out of 137 in the Medicine - Ophthalmology category, indicating its strong impact within the academic community. With a current impact factor that places it in the Q2 quartile for both Medicine (miscellaneous) and Ophthalmology as of 2023, it offers researchers and practitioners access to important findings and developments in eye health. The journal's converged years from 1991 to 2024 exemplify its longstanding commitment to the field, making it an essential resource for anyone looking to stay at the forefront of ophthalmological research.

CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE

Empowering professionals with cutting-edge insights.
Publisher: CANADIAN OPHTHAL SOCISSN: 0008-4182Frequency: 6 issues/year

Canadian Journal of Ophthalmology - Journal Canadien d'Ophtalmologie, published by the prestigious Canadian Ophthalmological Society, serves as a leading platform for disseminating cutting-edge research in the field of ophthalmology. With an ISSN of 0008-4182 and E-ISSN 1715-3360, the journal boasts a commendable impact factor and maintains a strong presence within the medicine and ophthalmology categories, ranking in the Q2 quartile. This journal not only provides significant insights into clinical practices and advancements but also contributes to the understanding of ocular health issues facing contemporary society. Since its inception in 1966, it has published high-quality research, making substantial strides in both practical and theoretical aspects of ophthalmology until 2024. Although it is not an open-access journal, it establishes a vital resource for researchers, professionals, and students alike, fostering an informed community dedicated to improving vision care.

Therapeutic Advances in Ophthalmology

Transforming vision care through accessible knowledge.
Publisher: SAGE PUBLICATIONS LTDISSN: 2515-8414Frequency: 1 issue/year

Therapeutic Advances in Ophthalmology is a leading open-access journal published by SAGE Publications Ltd, dedicated to advancing the understanding and treatment of ocular diseases. Since its inception in 2018, this journal has swiftly gained prominence within the ophthalmology community, proudly holding a Q1 designation in the 2023 category quartiles and ranking 34 out of 137 in the Scopus Medicine_Ophthalmology category, placing it in the top 75th percentile. By providing a platform for innovative research, clinical advancements, and educational resources, Therapeutic Advances in Ophthalmology serves as an essential resource for researchers, healthcare professionals, and students in the field. With a commitment to disseminating high-quality research accessible to all, this journal plays a critical role in shaping the future of ophthalmic care and treatment, enabling professionals to stay abreast of the latest developments and best practices in the discipline.

Journal of Ophthalmic Inflammation and Infection

Transforming insights into impactful clinical practices.
Publisher: SPRINGERISSN: 1869-5760Frequency: 1 issue/year

The Journal of Ophthalmic Inflammation and Infection, published by SPRINGER since 2011, stands as a pivotal resource for professionals in the fields of ophthalmology and infectious diseases. With an impactful Q2 ranking in both categories as of 2023, this open access journal is dedicated to disseminating high-quality research and reviews related to ocular inflammation and its infectious causes, fostering a deeper understanding of these critical health issues. The journal is well-regarded in the academic community, currently positioned at Rank #43 in Ophthalmology, reflecting its significance and influence within the discipline. The journal is accessible globally from its base in Germany, offering valuable insights to researchers, healthcare professionals, and students alike. With a commitment to excellence in publishing through 2024 and beyond, this journal continues to contribute meaningfully to innovative studies and clinical practices in ocular health.

Ocular Surface

Leading the Charge in Ocular Surface Advancements
Publisher: ELSEVIERISSN: 1542-0124Frequency: 4 issues/year

Ocular Surface, published by Elsevier, stands at the forefront of ophthalmology research, with a notable Impact Factor reflecting its significant contribution to the field. As a vibrant platform for disseminating cutting-edge findings, this journal has achieved Q1 ranking in the Ophthalmology category as of 2023, placing it amongst the top-tier journals globally, specifically ranking 4th out of 137 in Scopus with an impressive 97th percentile. Spanning across the years from 2003 to 2024, Ocular Surface focuses on advancing knowledge in areas such as ocular pathology, therapy, and surgical interventions. While the journal is not open access, it provides invaluable insights and empirical data essential for researchers, professionals, and students dedicated to improving ocular health. With an address rooted in Amsterdam, Netherlands, this esteemed journal continues to enrich the global conversation in ophthalmology.

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE

Exploring the depths of visual health.
Publisher: ASSOC RESEARCH VISION OPHTHALMOLOGY INCISSN: 0146-0404Frequency: 12 issues/year

Investigative Ophthalmology & Visual Science (IOVS) is a leading academic journal published by the Association for Research in Vision and Ophthalmology, dedicated to advancing the field of ophthalmology and visual science. With an impressive impact factor and ranking in the Q1 category for both Ophthalmology and Sensory Systems, IOVS is well-respected for disseminating cutting-edge research and innovative discoveries. Established in 1977, this Open Access journal allows for broad accessibility to pioneering studies, fostering collaboration among researchers, clinicians, and students. The journal has consistently maintained high visibility in the academic community, evidenced by its robust rankings in Scopus, including Rank #16 in Ophthalmology. As it continues to pave the way for future developments in the understanding and treatment of ocular diseases, IOVS serves as an invaluable resource for those immersed in the complex field of visual science.

Journal of Optometry

Pioneering research in optometry and eye health.
Publisher: ELSEVIERISSN: 1888-4296Frequency: 4 issues/year

The Journal of Optometry, published by Elsevier, is a leading open access journal dedicated to advancing the field of optometry and vision science. With an ISSN of 1888-4296 and an E-ISSN of 1989-1342, this journal serves as a pivotal platform for researchers, practitioners, and academics alike to disseminate and engage with high-quality original research and review articles. As of 2023, the journal holds an impressive Q2 ranking in the Optometry category, demonstrating its influence and relevance, particularly as it ranks #2 out of 12 in the Health Professions - Optometry category on Scopus with an 87th percentile. Since becoming open access in 2008, the Journal of Optometry has prioritized accessibility and the exchange of ideas, enriching the scholarly community and enhancing practical application in clinical settings. The journal welcomes submissions that push the boundaries of ocular research, clinical practices, and the education of optometry professionals, making it an essential resource for anyone invested in the future of eye health.

OPHTHALMOLOGY

Advancing ocular health through groundbreaking research.
Publisher: ELSEVIER SCIENCE INCISSN: 0161-6420Frequency: 12 issues/year

OPHTHALMOLOGY is a leading journal in the field of ocular health, widely recognized for its contributions to advancing the understanding and treatment of ophthalmic conditions. Published by ELSEVIER SCIENCE INC in the United States, it has earned a prestigious place within the academic community, boasting a remarkable Q1 ranking in the ophthalmology category for 2023, along with an impressive Scopus rank of #2 out of 137, placing it in the 98th percentile. With a strong publication history dating back to 1958, OPHTHALMOLOGY encompasses high-quality research articles, reviews, and clinical studies that address critical issues in the field. Researchers, professionals, and students alike can access its comprehensive research through traditional subscription options, fostering an ongoing dialogue among experts. Whether you are seeking the latest treatments, understanding complex ocular diseases, or looking to advance your knowledge, OPHTHALMOLOGY remains an essential resource for cutting-edge research and insights.

Turk Oftalmoloji Dergisi-Turkish Journal of Ophthalmology

Illuminating Innovations in Ophthalmology
Publisher: GALENOS PUBL HOUSEISSN: 1300-0659Frequency: 6 issues/year

Turk Oftalmoloji Dergisi - Turkish Journal of Ophthalmology is a premier peer-reviewed publication dedicated to the field of ophthalmology, published by GALENOS PUBL HOUSE. Since its inception in 1997, this Open Access journal has championed the dissemination of high-quality research, fostering an inclusive environment for sharing knowledge and advancements in eye health. With an ISSN of 1300-0659 and an E-ISSN of 2147-2661, the journal serves as a vital resource for researchers, clinicians, and students interested in the latest findings and innovations in ophthalmic sciences. Although its coverage in Scopus has been discontinued since 2017, the journal has garnered a significant rank of 80 out of 114 in the field of Medicine – Ophthalmology, highlighting its relevance and impact within the discipline. Operating out of Istanbul, Turkey, the Turkish Journal of Ophthalmology continues to be a crucial platform for ophthalmologists and researchers to publish their work and advance the understanding of ocular health.

Journal of Ophthalmology

Fostering Collaboration for a Brighter Vision
Publisher: HINDAWI LTDISSN: 2090-004XFrequency: 1 issue/year

The Journal of Ophthalmology, published by HINDAWI LTD, is an esteemed open-access journal that has been disseminating significant research in the field of ophthalmology since 2009. With an ISSN of 2090-004X and an E-ISSN of 2090-0058, this journal facilitates global access to cutting-edge studies, making it an essential resource for researchers, clinicians, and students alike. Ranked in the Q2 category of ophthalmology for 2023, the journal holds a commendable position with a Scopus rank of #37 out of 137 in its field, placing it in the 73rd percentile. The journal encompasses a variety of topics such as clinical advancements, surgical techniques, and innovative technologies in eye care, aiming to advance scientific knowledge and clinical practice in ophthalmology. By providing a platform for both novel research and comprehensive reviews, the Journal of Ophthalmology is instrumental in fostering collaboration and scholarly communication within the global eye health community, and its commitment to open access ensures that impactful research reaches a wide audience without barriers.